Nobuhiro Yaoita Selected Research

Nobuhiro Yaoita Research Topics

Disease

10	Pulmonary Hypertension 08/2020 - 09/2014
6	Hypoxia (Hypoxemia) 01/2020 - 04/2017
6	Pulmonary Arterial Hypertension 12/2019 - 01/2016
2	Heart Failure 01/2020 - 01/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2019 - 01/2017
1	Pathologic Constriction (Stenosis) 03/2020
1	Myocardial Infarction 12/2019
1	Parasitic Diseases (Parasitic Disease) 10/2019
1	Pulmonary Edema 01/2019
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Atrial Heart Septal Defects (Atrial Septal Defect) 12/2017
1	Vascular Remodeling 04/2017
1	Thrombosis (Thrombus) 04/2017
1	Fabry Disease (Fabry's Disease) 11/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Insulin Resistance 01/2016
1	Hepatopulmonary Syndrome 01/2016
1	Neoplasms (Cancer) 10/2014
1	Trypanosomiasis 10/2014
1	Malaria 10/2014
1	Inflammation (Inflammations) 09/2014
1	Heart Diseases (Heart Disease) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2013
1	Cardiomyopathies (Cardiomyopathy) 01/2013
1	Heart Valve Diseases (Valvular Heart Disease) 01/2013

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	Cyclophilin AIBA 01/2020 - 01/2017
2	Selenoprotein PIBA 12/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2018
2	Vasodilator Agents (Vasodilators)IBA 01/2019 - 01/2016
1	riociguatIBA 08/2020
1	TroponinIBA 01/2020
1	Natriuretic PeptidesIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Complement Factor D (Factor D)IBA 12/2019
1	Metalloproteases (Metalloproteinases)IBA 10/2019
1	Mebendazole (Anti-Worm)FDA Link 10/2019
1	DisintegrinsIBA 10/2019
1	ThrombospondinsIBA 10/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Thrombin FDA Link 04/2017
1	ThrombomodulinIBA 04/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	C-Reactive ProteinIBA 01/2017
1	GadoliniumIBA 11/2016
1	3-Iodobenzylguanidine (Iobenguane)IBA 11/2016
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2016
1	AlbuminsIBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	CreatinineIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Guanosine Triphosphate (GTP)IBA 11/2014
1	Pyridoxal KinaseIBA 10/2014
1	PyridoxalIBA 10/2014
1	Primaquine FDA Link 10/2014
1	Phosphotransferases (Kinase)IBA 10/2014
1	quinolineIBA 10/2014
1	Chloroquine (Aralen)FDA LinkGeneric 10/2014
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 09/2014
1	rho-Associated KinasesIBA 01/2013

Therapy/Procedure

6	Therapeutics 12/2019 - 10/2014
2	Patient Readmission 12/2019 - 01/2017
1	Stents 03/2020
1	Lung Transplantation 12/2017
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 11/2017
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2016